NF2 Loss (Merlin) — Targeted Therapies, Trials & Pipeline
Biallelic inactivation of the NF2 tumor-suppressor gene (encoding Merlin) occurs in ~40–50% of malignant pleural mesothelioma and silences upstream Hippo kinase signaling, unleashing constitutive YAP/TAZ-TEAD transcriptional oncogenesis.